Scientific Sessions

Recent advancements in diagnostic technologies have significantly transformed the detection, monitoring, and management of infectious diseases. Traditional diagnostic methods such as culture techniques and microscopy, while effective, often require extended turnaround times and skilled personnel. Modern innovations focus on speed, accuracy, and accessibility, enabling earlier intervention and improved patient outcomes. Molecular diagnostics, particularly polymerase chain reaction (PCR) and its real-time variant (RT-PCR), have become gold standards for detecting pathogens with high sensitivity and specificity. Next-generation sequencing (NGS) now allows for comprehensive pathogen profiling, facilitating rapid identification of novel or drug-resistant strains. Point-of-care (POC) diagnostic tools, including rapid antigen and antibody tests, have been instrumental in managing outbreaks, especially in resource-limited settings. These technologies reduce reliance on centralized laboratories and enable on-site decision-making, which is critical in controlling disease spread. Integration of artificial intelligence (AI) and machine learning into diagnostic platforms has further enhanced predictive analytics, interpretation of complex datasets, and early detection of infection patterns.

In addition to molecular and digital innovations, biosensor-based diagnostics and microfluidic devices are emerging as promising tools for rapid, cost-effective, and portable testing. These platforms use minimal sample volumes and provide results in minutes, making them ideal for community-level screening during epidemics. CRISPR-based diagnostics, such as SHERLOCK and DETECTR, have demonstrated remarkable potential in accurately detecting viral and bacterial infections at low costs and without sophisticated laboratory infrastructure. Furthermore, wearable health monitoring devices integrated with biosensors are opening new avenues for real-time detection of biomarkers associated with infections, offering continuous surveillance in high-risk populations. The use of telemedicine-linked diagnostic kits allows healthcare providers to remotely assess results, ensuring timely treatment even in geographically isolated areas. Collectively, these innovations not only enhance diagnostic accuracy but also strengthen global preparedness for emerging infectious diseases. As research continues, the focus is shifting toward developing scalable, affordable, and environmentally sustainable diagnostic solutions that can be deployed rapidly during pandemics, ultimately bridging gaps between technological advancements and public health needs.